Categories: NewsPharmaceutical

Stop Recalls Before They Start: Advanced 3D Laser Scanning for Food & Medical Packaging Inspection

BEDFORD, N.H., July 23, 2025 /PRNewswire/ — BOLD Laser Automation, Inc., is pleased to introduce its latest innovation: the DS1250LJX Dual Scanner Pre-Inspection Platform, purpose-built for IP69K-rated hostile environments. Designed for rigorous food and medical packaging lines, this system integrates the Keyence LJX and LJS series 2D/3D laser line scanners, providing a critical quality control step prior to fill operations—a move that reduces the risk of contamination and recalls. 

“Even with the most diligent packaging practices, an entire product batch can be derailed by a fragment of plastic, a trace of dust, or misapplied adhesive,” said Todd Lizotte, CEO and co-founder of Bold Laser Automation. “Product recalls can also lead to costly lawsuits and damage to brand trust. Our system avoids these mishaps in the first place.”

2D/3D Inspection in Harsh Environments

What sets the DS1250LJX apart is its rugged design for heat, humidity, and high-pressure washdown environments, common in food, beverage, and pharmaceutical production lines. The integrated Keyence LJX and LJS laser profilers deliver real-time, high-resolution 2D/3D surface data capable of detecting minute debris, surface inconsistencies, and embedded contamination—even when present inside transparent or translucent containers.

The dual-scanner configuration provides complete scanning, ensuring full surface coverage of each package before it reaches the fill station. This system-level precision and redundancy means threats are detected that can be missed by visual inspection and standard machine-vision.

Minimizing Production Disruptions

Bold’s design experts determine the optimal mounts and location for positioning the scanning assembly. The system connects to the existing PLC of the fill system, enabling seamless operator control. Motion control, scanning stage, and associated enclosures are rated for IP69K environments, ensuring reliable operation in demanding production conditions.

“In a competitive market, where one quality slip can shift customer loyalty, the cost of not having such a system is far greater than the cost of implementation,” said Lizotte. “The DS1250LJX platform protects brands from the downstream effects of defective packaging and contamination leading to product recalls and FDA investigations.”

The DS1250LJX not only prevents contamination but also supports lean manufacturing and traceability initiatives, integrating seamlessly with MES and QMS platforms. Early detection ensures that packaging lines run cleaner and faster, with less downtime and fewer customer complaints.

“This system not only enhances the inspection process but also streamlines production by proactively identifying potential issues,” added Lizotte.

About BOLD Laser Automation, Inc.
BOLD Laser Automation designs and manufactures advanced laser and metrology systems for precision manufacturing and inspection. Headquartered in Bedford, NH, Bold serves food, medical, aerospace, electronics, and industrial sectors, specializing in platforms for harsh environments and mission-critical applications.

Explore “Laser Beam Shaping Applications, Second Edition, 2017” Todd E. Lizotte: Click here.

Media Contact:
Todd E. Lizotte, CEO and Co-founder, 603-413-5601
398465@email4pr.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/stop-recalls-before-they-start-advanced-3d-laser-scanning-for-food–medical-packaging-inspection-302511021.html

SOURCE Bold Laser Automation

Staff

Recent Posts

Accelerating Patient Recruitment and Research Excellence: TrialWire® Supports Endpoints Clinical Trials Day NYC 2025

NEW YORK, Dec. 12, 2025 (GLOBE NEWSWIRE) -- TrialWire®, the industry’s fastest, intelligent patient recruitment…

39 minutes ago

Genesis Healthcare Remains Committed to Securing Longterm Stability

The skilled nursing, assisted and senior living provider reiterates dedication to a financial restructuring process…

39 minutes ago

Extendicare Announces December 2025 Dividend of C$0.042 per Share

MARKHAM, Ontario, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX:…

39 minutes ago

Teva to Host Conference Call to Discuss Fourth Quarter 2025 Financial Results at 8 a.m. ET on January 28, 2026

TEL AVIV, Israel, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and…

40 minutes ago

Teva Releases Q4 2025 Aide Memoire

TEL AVIV, Israel, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and…

40 minutes ago